Leslie Tari's most recent trade in Cidara Therapeutics Inc was a trade of 1,773 Common Stock done at an average price of $22.0 . Disclosure was reported to the exchange on March 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 11 Mar 2025 | 1,773 | 16,215 (0%) | 0% | 22.0 | 38,940 | Common Stock |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 30 Sep 2024 | 150,224 | 150,224 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 11 Sep 2024 | 909 | 17,788 (0%) | 0% | 11.6 | 10,580 | Common Stock | |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 15 Mar 2024 | 222,500 | 222,500 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 15 Mar 2024 | 111,250 | 369,931 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 11 Mar 2024 | 21,029 | 258,681 (0%) | 0% | 0.7 | 14,085 | Common Stock | |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 14 Aug 2023 | 10,000 | 294,179 (0%) | 0% | 1.0 | 9,700 | Common Stock | |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 27 Mar 2023 | 180,000 | 180,000 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 27 Mar 2023 | 90,000 | 280,179 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 13 Mar 2023 | 7,562 | 190,179 (0%) | 0% | 1.5 | 11,570 | Common Stock | |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 12 Jan 2023 | 11,814 | 1,484 (0%) | 0% | 1.2 | 14,177 | Common Stock | |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 12 Sep 2022 | 18,159 | 193,741 (0%) | 0% | 0.7 | 12,437 | Common Stock | |
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 31 Mar 2022 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 31 Mar 2022 | 52,500 | 207,900 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 30 Sep 2021 | 148,000 | 150,551 (0%) | 0% | 0 | Common Stock |